US Stock MarketDetailed Quotes

LSB LakeShore Biopharma

Watchlist
  • 2.245
  • +0.085+3.94%
Trading Nov 4 12:20 ET
42.84MMarket Cap-394P/E (TTM)

LakeShore Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
(FY)Mar 31, 2022
(FY)Mar 31, 2021
Total revenue
-16.56%573.42M
-50.11%96.82M
-14.21%176.27M
36.63%687.2M
194.06M
205.48M
95.69%502.95M
257.02M
Operating revenue
-16.56%573.42M
-50.11%96.82M
-14.21%176.27M
36.63%687.2M
--194.06M
--205.48M
95.69%502.95M
--257.02M
Cost of revenue
-23.26%117.69M
-58.87%17.51M
-32.18%34.68M
31.00%153.36M
42.57M
51.13M
96.23%117.07M
59.66M
Gross profit
-14.63%455.73M
-47.65%79.31M
-8.26%141.59M
38.34%533.84M
151.49M
154.34M
95.52%385.88M
197.36M
Operating expense
13.25%723.44M
32.72%179.36M
26.55%210.17M
35.18%638.82M
135.14M
166.08M
47.83%472.58M
319.68M
Selling and administrative expenses
28.43%428.09M
10.10%114.3M
15.63%111.01M
22.20%333.32M
--103.81M
--96M
30.93%272.77M
--208.33M
-Selling and marketing expense
11.48%280.45M
-1.54%78.51M
12.34%79.2M
51.80%251.56M
--79.74M
--70.49M
138.66%165.72M
--69.44M
-General and administrative expense
80.58%147.65M
48.67%35.8M
24.71%31.81M
-23.62%81.76M
--24.08M
--25.51M
-22.93%107.05M
--138.89M
Research and development costs
-4.99%302.8M
45.99%78.21M
43.18%100.64M
50.88%318.7M
--53.57M
--70.29M
123.78%211.22M
--94.39M
Depreciation amortization depletion
2.08%6.46M
----
----
5.56%6.33M
----
----
-36.79%6M
--9.49M
-Depreciation and amortization
2.08%6.46M
----
----
5.56%6.33M
----
----
-36.79%6M
--9.49M
Provision for doubtful accounts
----
----
----
----
----
----
----
--7M
Other taxes
3.79%6.79M
----
----
16.57%6.54M
----
----
40.13%5.61M
--4M
Other operating expenses
20.57%-20.71M
40.87%-13.15M
-601.90%-1.47M
-13.26%-26.07M
---22.25M
---210K
-552.06%-23.02M
---3.53M
Operating profit
-155.00%-267.71M
-711.84%-100.05M
-484.26%-68.58M
-21.10%-104.98M
16.35M
-11.74M
29.12%-86.69M
-122.32M
Net non-operating interest income expense
-43.71%-44.34M
34.77%-4.94M
-8.85%-8.03M
-1,035.54%-30.86M
-7.57M
-7.38M
90.85%-2.72M
-29.69M
Non-operating interest expense
43.71%44.34M
-12.02%6.9M
8.85%8.03M
1,035.54%30.86M
--7.84M
--7.38M
-90.85%2.72M
--29.69M
Other net income (expense)
-1,521.08%-143.14M
37.32%-223.62K
4,809.09%6.48M
24.25%-8.83M
-356.74K
132K
47.88%-11.66M
-22.36M
Gain on sale of security
20,776.69%4.46M
--158.31K
--6.69M
--21.36K
----
----
----
----
Special income (charges)
-1,718.68%-157.42M
----
----
8.66%-8.66M
----
----
---9.48M
----
-Less:Impairment of capital assets
1,718.68%157.42M
----
----
-8.66%8.66M
----
----
--9.48M
----
Other non- operating income (expenses)
5,112.13%9.82M
-7.06%-381.93K
-261.36%-213K
91.02%-195.85K
---356.74K
--132K
90.25%-2.18M
---22.36M
Income before tax
-215.35%-455.19M
-1,349.40%-105.22M
-269.46%-70.13M
-42.82%-144.35M
8.42M
-18.98M
42.04%-101.07M
-174.37M
Income tax
-2,016.94%-21.73M
-405.34%-234.35K
-195.75%-586K
-77.04%1.13M
-46.38K
612K
-71.71%4.94M
17.45M
Net income
-197.96%-433.46M
-1,339.79%-104.98M
-254.93%-69.54M
-37.24%-145.48M
8.47M
-19.59M
44.74%-106M
-191.83M
Net income continuous Operations
-197.96%-433.46M
-1,339.79%-104.98M
-254.93%-69.54M
-37.24%-145.48M
--8.47M
---19.59M
44.74%-106M
---191.83M
Minority interest income
Net income attributable to the parent company
-197.96%-433.46M
-1,339.79%-104.98M
-254.93%-69.54M
-37.24%-145.48M
8.47M
-19.59M
44.74%-106M
-191.83M
Preferred stock dividends
Other preferred stock dividends
0
0
0
5.61%137.99M
37.61M
34.47M
686.63%130.66M
16.61M
Net income attributable to common stockholders
-52.91%-433.46M
-260.23%-104.98M
-28.62%-69.54M
-19.78%-283.47M
-29.14M
-54.07M
-13.54%-236.67M
-208.44M
Basic earnings per share
-32.95%-40.5
-258.26%-11.327
-27.40%-7.473
-18.64%-30.4617
-3.1617
-5.8656
-13.54%-25.6758
-22.6131
Diluted earnings per share
-32.95%-40.5
-258.26%-11.327
-27.40%-7.473
-18.64%-30.4617
-3.1617
-5.8656
-13.54%-25.6758
-22.6131
Dividend per share
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q2)Sep 30, 2022(Q1)Jun 30, 2022(FY)Mar 31, 2022(FY)Mar 31, 2021
Total revenue -16.56%573.42M-50.11%96.82M-14.21%176.27M36.63%687.2M194.06M205.48M95.69%502.95M257.02M
Operating revenue -16.56%573.42M-50.11%96.82M-14.21%176.27M36.63%687.2M--194.06M--205.48M95.69%502.95M--257.02M
Cost of revenue -23.26%117.69M-58.87%17.51M-32.18%34.68M31.00%153.36M42.57M51.13M96.23%117.07M59.66M
Gross profit -14.63%455.73M-47.65%79.31M-8.26%141.59M38.34%533.84M151.49M154.34M95.52%385.88M197.36M
Operating expense 13.25%723.44M32.72%179.36M26.55%210.17M35.18%638.82M135.14M166.08M47.83%472.58M319.68M
Selling and administrative expenses 28.43%428.09M10.10%114.3M15.63%111.01M22.20%333.32M--103.81M--96M30.93%272.77M--208.33M
-Selling and marketing expense 11.48%280.45M-1.54%78.51M12.34%79.2M51.80%251.56M--79.74M--70.49M138.66%165.72M--69.44M
-General and administrative expense 80.58%147.65M48.67%35.8M24.71%31.81M-23.62%81.76M--24.08M--25.51M-22.93%107.05M--138.89M
Research and development costs -4.99%302.8M45.99%78.21M43.18%100.64M50.88%318.7M--53.57M--70.29M123.78%211.22M--94.39M
Depreciation amortization depletion 2.08%6.46M--------5.56%6.33M---------36.79%6M--9.49M
-Depreciation and amortization 2.08%6.46M--------5.56%6.33M---------36.79%6M--9.49M
Provision for doubtful accounts ------------------------------7M
Other taxes 3.79%6.79M--------16.57%6.54M--------40.13%5.61M--4M
Other operating expenses 20.57%-20.71M40.87%-13.15M-601.90%-1.47M-13.26%-26.07M---22.25M---210K-552.06%-23.02M---3.53M
Operating profit -155.00%-267.71M-711.84%-100.05M-484.26%-68.58M-21.10%-104.98M16.35M-11.74M29.12%-86.69M-122.32M
Net non-operating interest income expense -43.71%-44.34M34.77%-4.94M-8.85%-8.03M-1,035.54%-30.86M-7.57M-7.38M90.85%-2.72M-29.69M
Non-operating interest expense 43.71%44.34M-12.02%6.9M8.85%8.03M1,035.54%30.86M--7.84M--7.38M-90.85%2.72M--29.69M
Other net income (expense) -1,521.08%-143.14M37.32%-223.62K4,809.09%6.48M24.25%-8.83M-356.74K132K47.88%-11.66M-22.36M
Gain on sale of security 20,776.69%4.46M--158.31K--6.69M--21.36K----------------
Special income (charges) -1,718.68%-157.42M--------8.66%-8.66M-----------9.48M----
-Less:Impairment of capital assets 1,718.68%157.42M---------8.66%8.66M----------9.48M----
Other non- operating income (expenses) 5,112.13%9.82M-7.06%-381.93K-261.36%-213K91.02%-195.85K---356.74K--132K90.25%-2.18M---22.36M
Income before tax -215.35%-455.19M-1,349.40%-105.22M-269.46%-70.13M-42.82%-144.35M8.42M-18.98M42.04%-101.07M-174.37M
Income tax -2,016.94%-21.73M-405.34%-234.35K-195.75%-586K-77.04%1.13M-46.38K612K-71.71%4.94M17.45M
Net income -197.96%-433.46M-1,339.79%-104.98M-254.93%-69.54M-37.24%-145.48M8.47M-19.59M44.74%-106M-191.83M
Net income continuous Operations -197.96%-433.46M-1,339.79%-104.98M-254.93%-69.54M-37.24%-145.48M--8.47M---19.59M44.74%-106M---191.83M
Minority interest income
Net income attributable to the parent company -197.96%-433.46M-1,339.79%-104.98M-254.93%-69.54M-37.24%-145.48M8.47M-19.59M44.74%-106M-191.83M
Preferred stock dividends
Other preferred stock dividends 0005.61%137.99M37.61M34.47M686.63%130.66M16.61M
Net income attributable to common stockholders -52.91%-433.46M-260.23%-104.98M-28.62%-69.54M-19.78%-283.47M-29.14M-54.07M-13.54%-236.67M-208.44M
Basic earnings per share -32.95%-40.5-258.26%-11.327-27.40%-7.473-18.64%-30.4617-3.1617-5.8656-13.54%-25.6758-22.6131
Diluted earnings per share -32.95%-40.5-258.26%-11.327-27.40%-7.473-18.64%-30.4617-3.1617-5.8656-13.54%-25.6758-22.6131
Dividend per share
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Audit Opinions Unqualified Opinion with Explanatory Notes----Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data